Angiodynamics Inc SEC filings ANGO

Angiodynamics Inc has 1,002 filings in SEC EDGAR's recent list, going back to Aug 24, 2011. Its latest annual report, Form 10-K, was filed on Jul 14, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 8, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on May 31.

Angiodynamics Inc SEC filings
Form Description Filed Period
UPLOAD Letter from the SEC Mar 22, 2024 —
CORRESP Letter to the SEC Mar 6, 2024 —
UPLOAD Letter from the SEC Feb 22, 2024 —
UPLOAD Letter from the SEC Apr 4, 2018 —
CORRESP Letter to the SEC Mar 30, 2018 —
UPLOAD Letter from the SEC Jan 9, 2018 —
NT 10-Q Form 12b-25 Oct 10, 2014 Aug 31, 2014
EFFECT Filing Oct 11, 2013 —
UPLOAD Letter from the SEC Sep 19, 2012 —
CORRESP Letter to the SEC Sep 18, 2012 —
UPLOAD Letter from the SEC Sep 4, 2012 —
8-A12G/A Amendment no. 1 Feb 3, 2012 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANGO (Nasdaq)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Latham, NY
SEC filer status
Accelerated filer
SEC CIK
1275187

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.